Archives

SAN FRANCISCO, Feb. 28, 2020 (CLINICAL OMICS) – A retrospective study among head and neck cancer patients found that a multivariate RNA biomarker test performed equally as standard PD-L1 [...]

By Zachary Bradley   Cell Surface Markers The human body is a complex environment made up of many different types of cells interacting with one another as well as their environment. In order [...]

By Kevin Flanagan, PhD Oncologists and cancer patients alike carefully track tumor status. The tumor is growing. The tumor is shrinking. The tumor has spread. The tumor is stable. There are new [...]

SAN FRANCISCO, Feb. 7, 2020 (DIAGNOSTIC WORLD) – Achieving true precision medicine in oncology continues to challenge the entire healthcare field—from clinicians to drug manufacturers to [...]

By Raymund Bueno, PhD Immunohistochemistry (IHC) is a method performed in the lab to identify specific antigens or analytes in a tissue sample using monoclonal or polyclonal antibodies¹ (see [...]

Cancer Molecular Subtypes Molecular subtyping refers to the use of -omics data to find clusters of tumors within a cancer type that have shared characteristics. Whereas earlier attempts to find [...]